Vagus Nerve Stimulator Market is Poised to Thrive at CAGR of 10.1% During 2022-2031 | TMR Study
April 17, 2023 16:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, April 18, 2023 (GLOBE NEWSWIRE) -- The global vagus nerve stimulator market size was worth USD 444.7 Mn in 2021 and is anticipated to exceed value of USD 1.1 Bn...
Timberline Knolls Offers Yoga Treatment That Incorporates the 12-Step Model
March 23, 2023 11:01 ET
|
Timberline Knolls
Chicago, March 23, 2023 (GLOBE NEWSWIRE) -- Timberline Knolls, a leading treatment center for women and adolescent girls who are struggling with eating disorders, trauma, substance use disorders,...
Global Behavioural Health Treatment Market is expected to witness a CAGR of 2.9% during the forecast period of 2022 to 2032 | Fact.MR Report
March 21, 2023 10:00 ET
|
FACT.MR
Rockville, March 21, 2023 (GLOBE NEWSWIRE) -- The market for Behavioural Health Treatments will expand at a CAGR of 2.9%, over the forecasted time. The rise of telepsychiatry procedures in the...
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
March 02, 2023 07:00 ET
|
GH Research PLC
DUBLIN, Ireland, March 02, 2023 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological...
NeuroSigma Announces New Telehealth Option for Patients and Caregivers Interested in eTNS for Pediatric ADHD
March 01, 2023 11:00 ET
|
NeuroSigma, Inc.
LOS ANGELES, March 01, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced a new option for patients and caregivers seeking a telehealth evaluation for the Monarch eTNS System®. NeuroSigma is a Los...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
February 03, 2023 00:01 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
Ehave Provides Progress Update on its HPPD Study with University of Melbourne
February 02, 2023 08:30 ET
|
Ehave
MIAMI, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the "Company"), a Healthcare Analytics provider with interests in the psychedelic and mental health sectors, is pleased to...
Depression Treatment Market will manager to achieve USD 15.0 billion by 2030 : GreyViews
January 24, 2023 11:30 ET
|
GreyViews
Pune India, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Canadian Men’s Health Foundation expands MindFit Toolkit to support more men with anxiety and depression
January 19, 2023 08:00 ET
|
Canadian Men's Health Foundation
VANCOUVER, British Columbia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The Canadian Men’s Health Foundation (CMHF) announced today new and expanded mental health resources for their MindFit Toolkit...
FDA Clears Magstim Transcranial Magnetic Stimulation for Obsessive Compulsive Disorder
January 18, 2023 13:05 ET
|
Magstim EGI
MINNEAPOLIS, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Magstim, a global leader in neuroscience research and Transcranial Magnetic Stimulation (TMS) solutions for mental health, announced today that the FDA...